[Research progress in endoscopic retrograde cholangiopancreatography-mediated photodynamic therapy for cholangiocarcinoma].

Abstract

The malignant degree of cholangiocarcinoma is high, and the early diagnosis is difficult. The vast majority of patients are unresectable when they are diagnosed. The patients have low quality of life and short survival cycle. Traditional radiotherapy and chemotherapy have poor efficacy and lead to side effects, and thus lack effective control measures for cholangiocarcinoma. Endoscopic retrograde cholangiopancreatography (ERCP) is an important method for diagnosing and treating biliary tract diseases. Photodynamic therapy (PDT) is a new local treatment for cholangiocarcinoma. In recent years, ERCP-mediated PDT treatment of cholangiocarcinoma has gradually emerged. ERCP-mediated PDT can effectively relieve the symptoms of patients with cholangiocarcinoma, improve the patients' quality of life, prolong the survival cycle, and is expected to become a new treatment for cholangiocarcinoma.

• Authors: Kunpeng Wang, Li Xiong, Zijian Zhang, Kai Liu, Yunpeng Huang, Xin Yang, Qinglong Li, Wei Chen, Heng Zou, Yu Wen
• Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences (Zhong Nan Da Xue Xue Bao Yi Xue Ban) Vol. 44 Issue 11 Pg. 1275-1280 (Nov 28 2019) ISSN: 1672-7347 [Print] China
• PMID: 31919323 (Publication Type: Journal Article)

Topics

• Bile Duct Neoplasms (diagnosis)
• Bile Ducts, Intrahepatic
• Cholangiocarcinoma (diagnosis)
• Cholangiopancreatography, Endoscopic Retrograde
• Humans
• Photochemotherapy
• Quality of Life